Motor and cognitive improvements in patients with Huntington's disease after neural transplantation

Lancet

Volumn 356, Issue 9246, 2000, Pages 1975-1979

  Bachoud Lévi, Anne Catherine ^a   Rémy, Philippe ^b   Nǵuyen, Jean Paul ^a   Brugières, Pierre ^a   Lefaucheur, Jean Pascal ^a   Bourdet, Catherine ^c   Baudic, Sophie ^d   Gaura, Véronique ^e   Maison, Patrick ^a   Haddad, Bassam ^f   Boissé, Marie Françoise ^a   Grandmougin, Thierry ^c   Jény, Roland ^g   Bartolomeo, Paolo ^d   Barba, Gianfranco Dalla ^d   Degos, Jean Denis ^a   Lisovoski, Fabrice ^d   Ergis, Anne Marie ^a   Pailhous, Edwige ^c   Cesaro, Pierre ^a   Hantraye, Philippe ^e   Peschanski, Marc ^d   more..

^a HENRI MONDOR HOSPITAL   (France)

^b SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^c Hopital Albert Chenevier   (France)

^d INSERM   (France)

^e DIF   (France)

^f CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^g Hopital Esquirol   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN METABOLISM; CASE REPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS STRIATUM; FETUS; FOLLOW UP; GRAFT SURVIVAL; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; NEUROBLAST; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

EID: 0034627143     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)03310-9     Document Type: Article

References (26)

1. Striatial grafts in rats with unilateral neostriatal lesions, I: Ultrastructural evidence of afferent synaptic inputs from the host nigrostriatal pathway
2. Striatal grafts in rats with unilateral neostriatal lesions, II: In vivo monitoring of GABA release in globus pallidus and subtantia nigra
3. Striatal grafts in rats with unilateral neostriatal lesions, III: Recovery from dopamine-dependent motor asymmetry and deficits in skilled paw reaching
4. Functional integration of striatal allografts in a primate model of Huntington's disease
5. Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease
6. Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease
7. Development of the human striatum: Implications for fetal striatal transplantation in the treatment of Huntington's disease
8. Neural transplantation for Huntington's disease: Experimental rationale and recommendations for clinical trials
9. Repair of the damaged brain
10. Cerebral implantation in movement disorders: State of the art
11. The need for phase III studies in experimental surgical treatments of Parkinson's disease
12. Safety of intrastriatal neurotransplantation for Huntington's disease patients
13. Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease
14. A prospective evaluation of cognitive decline in early Huntington's disease: Functional and radiographic correlates
15. Influence of lamotrigine on progression of early Huntington disease: A randomized clinical trial
16. Core Assessment Program for Intracerebral Transplantation in Huntington's Disease (CAPIT-HD)
17. MRI-stereotactical approach for neural grafting in basal ganglia disorders
18. Unified Huntington's disease rating scale: Reliability and consistency
19. The [14C] deoxyglucose method for the measurement of local cerebral glucose utilisation
20. Fast nonsupervised 3D registration of PET and MR images of the brain
21. Effect of repeated administration of a neuropsychological battery in the elderly
22. Neuropsychological stability over two years in asymptomatic carriers of the Huntington's disease mutation
23. Rate of functional decline in Huntington's disease
24. Ontogeny of human striatal DARPP-32 neurons in fetuses and following xenografting to the adult rat brain
25. Long-term delayed vascularization of human neural transplants to the rat brain
26. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient